Imaging results, follow-up evaluation and treatment
| Patient No | Cross sectional imaging findings (Fischer grade) | Initial angiographic evaluation | Arteriopathy distribution/grade | Time between documented SAH and arteriopathy (days) | Follow-up angiographic evaluation and results | Follow-up (days) | Treatment |
| 1 | Grade 2 SAH | DSA, CTA | Diffuse, severe | 8 | DSA, complete resolution | 172 | Ca Ch blocker, steroids |
| 2 | Grade 2 SAH, acute infarcts | DSA, CTA, MRA | Diffuse, severe | 11 | DSA, marked improvement | 13 | Ca Ch blocker, steroids, cyclophosphamide |
| 3 | Grade 2 SAH | DSA, MRA | Diffuse, mild | 1 | DSA, complete resolution | 10 | Ca Ch blocker |
| 4 | Grade 2 SAH | DSA, MRA | Diffuse, moderate | 4 | DSA, marked improvement | 57 | Steroids |
| 5 | Grade 1, acute infarcts | DSA, MRA | Diffuse, severe | No SAH | DSA, marked improvement | 31 | Steroids |
| 6 | Grade 2 SAH | DSA | Diffuse, mild | 0 | DSA, complete resolution | 35 | Ca Ch blocker |
| 7 | Grade 2 SAH | DSA | Diffuse, moderate | 0 | MRA, complete resolution | 43 | Observation |
| 8 | Grade 2 SAH | DSA | Diffuse, mild | 2 | DSA, complete resolution | 24 | Thorazine |
| 9 | Grade 2 SAH | DSA, MRA | Diffuse, mild | 0 | DSA, MRA, complete resolution | 60 | Ca Ch blocker |
| 10 | Grade 1, acute infarcts | DSA, MRA | Diffuse, severe | No SAH | DSA, complete resolution | 45 | Oxycontin, nortriptyline |
| 11 | Grade 2 SAH | MRA | Diffuse, severe | 0 | DSA, complete resolution | 83 | Ca Ch blocker |
Ca Ch blocker, calcium channel blocker; CTA, CT angiography; DSA, digital subtraction angiography; MRA, MR angiography; SAH, subarachnoid hemorrhage.